# Assessment of CataClear, Tear Film Stability, Tear Volume, and Dry Eye Symptoms Using Stem Cells Fortified Eye Drops

> **NCT07191847** · PHASE4 · RECRUITING · sponsor: **Ace Cells Lab Limited** · enrollment: 300 (estimated)

## Conditions studied

- Dry Eye
- Cataract

## Interventions

- **BIOLOGICAL:** eye drops

## Key facts

- **NCT ID:** NCT07191847
- **Lead sponsor:** Ace Cells Lab Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-22
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07191847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07191847, "Assessment of CataClear, Tear Film Stability, Tear Volume, and Dry Eye Symptoms Using Stem Cells Fortified Eye Drops". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07191847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*